Marijuana and Hemp Leaders Agree on Key Policy Issues (Op-Ed)
Unified THC regulation cannabis policy is gaining traction among marijuana and hemp leaders. This consensus aims to improve product quality, potency, and safety for patients. Clinicians benefit from clearer dosing guidelines and better clinical outcomes.
Kentucky Lawmakers Push Bill Regulating THC-Infused Beverages Like Alcohol
Kentucky is advancing legislation focused on THC beverage regulations to mirror alcohol oversight. These regulations address unique dosing and safety risks of THC-infused drinks. Clinicians must understand these changes to provide accurate patient…
Federal Marijuana Rescheduling May Speed Tennessee MMJ Legalization
Federal marijuana rescheduling Tennessee medical cannabis could remove barriers to clinical research and accelerate legalization in Tennessee. This shift allows clinicians to access evidence-based data for patient care. It also enables a legal framework…
Recreational Cannabis Laws May Displace Illegal Cannabis Markets
Research on recreational cannabis legalization impacts provides key insights into illegal market displacement. Legal markets may reduce reliance on unregulated cannabis sources, improving patient safety. Understanding these dynamics is crucial for…
Is Today’s Marijuana More Dangerous Than We Realize—Especially for Teens?
Modern cannabis potency risks are increasingly concerning for adolescent brain development. Higher THC levels in today's cannabis may lead to psychiatric symptoms and cannabis use disorder in teens. Clinicians should counsel patients and families about…
Optimizing Cannabis Dosing Protocols: Benefits and Risks
Cannabis dosing protocols are essential for maximizing medical benefits while reducing adverse effects. Understanding the THC-to-CBD ratio helps personalize treatment and improve safety. Clinicians should adopt careful titration strategies to optimize…
Cannabis Compounds Could Reverse Disease Affecting One-Third of Adults
Emerging research shows cannabis compounds reverse fatty liver disease in preclinical models. These findings highlight potential metabolic benefits of cannabis compounds. However, clinical evidence remains limited for cannabis compounds reverse fatty…
Exploring Cannabis Neuroprotective Benefits in Older Adults
Recent research highlights cannabis neuroprotective benefits older adults might experience, challenging traditional views on cognitive aging. These findings suggest potential brain health support from cannabis in elderly populations. Clinicians should…
Potency-related Effects of Smoked Cannabis on Simulated Driving Performance
Cannabis potency driving impairment significantly affects simulated driving performance, especially with higher THC levels. This dose-dependent effect is crucial for clinicians counseling patients on safe cannabis use. Understanding these risks helps…
In the Mix: Cannabis Regulation and Business Insights — March 10, 2026
This article reviews cannabis regulation business trends impacting clinical practice. It highlights legal uncertainty and the rise of minor cannabinoid products. Understanding cannabis regulation business challenges is key for clinicians and patients…
